Article Details
Retrieved on: 2022-04-11 18:59:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
GTB-5550 is the Company's B7H3-targeted tri-specific killer engager (TriKE) and is part of GT Biopharma's portfolio of TriKE product candidates being ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here